Home › Funds › PNC Financial Services › ABOS
PNC Financial Services position in ABOS
ACUMEN PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)3.08K sh
Reported value held$8.22K
Portfolio Weight0.00%
First reportedQ1 2025
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 4.45K | $4.89K | New |
| Q2 2025 | 4.95K | $5.74K | Add |
| Q3 2025 | 3.08K | $5.27K | Reduce |
| Q4 2025 | 3.08K | $6.50K | Hold |
| Q1 2026 | 3.08K | $7.27K | Hold |
| Q2 2026 | 3.08K | $8.22K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABOS
- BlackRock Inc 2.49M sh · $6.65M · Q2 2026
- Franklin Resources 2.31M sh · $6.15M · Q2 2026
- Vanguard Group 1.65M sh · $3.49M · Q4 2025
- Geode Capital Management 1.14M sh · $3.05M · Q2 2026
- Renaissance Technologies 675.02K sh · $1.80M · Q2 2026
- Two Sigma Investments 622.88K sh · $1.66M · Q2 2026
- Northern Trust Corp 360.74K sh · $963.19K · Q2 2026
- Bank of America Corp 274.78K sh · $733.66K · Q2 2026
- Goldman Sachs Group 183.93K sh · $491.08K · Q2 2026
- Morgan Stanley 136.76K sh · $365.16K · Q2 2026
- BNY Mellon 124.38K sh · $332.09K · Q2 2026
- Charles Schwab Investment Management 115.10K sh · $307.31K · Q2 2026